Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

Affiliations

• ¹ Department of Pediatrics, Columbia University Irving Medical Center, 1150 St. Nicholas Avenue, Room 620, New York, NY, 10032, USA.
• ² Department of Systems Biology, Columbia University, New York, NY, USA.
• ³ Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
• ⁴ Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
• ⁵ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
• ⁶ 42Genetics, Belfast, Ireland.
• ⁷ NIHR BioResource for Translational Research, Cambridge Biomedical Campus, Cambridge, UK.
• ⁸ Regeneron Pharmaceuticals, New York, NY, USA.
• ⁹ Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
• ¹⁰ Department of Medical and Molecular Genetics, King's College London, London, UK.
• ¹¹ National Heart & Lung Institute, Imperial College London, London, UK.
• ¹² Addenbrooke's Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
• ¹³ Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
• ¹⁴ Department of Biomedical Informatics, Columbia University, New York, NY, USA.
• ¹⁵ Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
• ¹⁶ Department of Pediatrics, Columbia University Irving Medical Center, 1150 St. Nicholas Avenue, Room 620, New York, NY, 10032, USA. wkc15@columbia.edu.
• ¹⁷ Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA. wkc15@columbia.edu.
• ¹⁸ Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. wkc15@columbia.edu.